Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery
The interaction of nanoparticles with a range of biomolecules once they have been injected within the body can affect their performance. Here, the authors demonstrate that squalene nanomaterials conjugated with anticancer drugs can interact with lipoproteins and can be used to target cancer cells.
Guardado en:
Autores principales: | Dunja Sobot, Simona Mura, Semen O. Yesylevskyy, Laura Dalbin, Fanny Cayre, Guillaume Bort, Julie Mougin, Didier Desmaële, Sinda Lepetre-Mouelhi, Grégory Pieters, Bohdan Andreiuk, Andrey S. Klymchenko, Jean-Louis Paul, Christophe Ramseyer, Patrick Couvreur |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/061aa937c3464c1992e959529c5f6d40 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The shape of human squalene epoxidase expands the arsenal against cancer
por: Andrew J. Brown, et al.
Publicado: (2019) -
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidase
por: Anil K. Padyana, et al.
Publicado: (2019) -
Positively charged cyclodextrins as effective molecular transporters of active phosphorylated forms of gemcitabine into cancer cells
por: Violeta Rodriguez-Ruiz, et al.
Publicado: (2017) -
Novel Photoinduced Squalene Cyclic Peroxide Identified, Detected, and Quantified in Human Skin Surface Lipids
por: Saoussane Khalifa, et al.
Publicado: (2021) -
A squalene synthase-like enzyme initiates production of tetraterpenoid hydrocarbons in Botryococcus braunii Race L
por: Hem R. Thapa, et al.
Publicado: (2016)